Barr Plans Move To OTC Market With Plan B Emergency Contraceptive
This article was originally published in The Tan Sheet
Barr Laboratories will continue to pursue an Rx-to-OTC switch for the emergency contraceptive Plan B following its planned acquisition of the product
You may also be interested in...
It was only after prolonged litigation led a federal judge in 2013 to order FDA not to allow political interference with its science-based decisions that Plan B and generic equivalents became available OTC without age restrictions. “Hopefully, all I can say, it won't happen again,” says reproductive rights advocate Kirsten Moore.
Barr hinted that it is leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the Plan B "morning after" pill
Barr's acquisition of rights to emergency contraceptive Preven from Gynetics gives the firm another potential Rx-to-OTC switch candidate